Harish Manwani Joins Gilead Sciences’ Board of Directors
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Harish M. Manwani has been appointed to the company’s Board of Directors.
Mr. Manwani is a Global Executive Advisor to the private equity business of Blackstone, a leading asset management company. He was previously Chief Operating Officer of the global consumer products company Unilever PLC. He began his career at Unilever in 1976 and held senior management positions in Unilever businesses around the world for nearly 40 years. He brings broad international operational expertise, having worked extensively in Asia, Africa, Europe and the Americas. Mr. Manwani is currently the Chairman of Hindustan Unilever Ltd., and serves on the Boards of Nielsen Holdings PLC, Qualcomm Inc. and Whirlpool Corp. He is also on the Board of Economic Development Board of Singapore and is the Chairman of the Board of Indian School of Business.
“We are very pleased to welcome Harish Manwani to our Board of Directors,” said John Milligan, Ph.D., President and Chief Executive Officer, Gilead Sciences. “Harish brings extensive experience in driving growth across complex organizations on a global scale. His expertise will help guide our strategy as Gilead continues to grow in new geographies and address unmet medical needs for people around the world.”
About Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Mark Snyder, 650-522-6167
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CA-GILEAD-SCIENCES-INC.10.12.2018 07:02 | Pressemeddelelse
Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer
SAMSUNG-BIOEPIS8.12.2018 15:12 | Pressemeddelelse
Samsung Bioepis Announces Results of Additional One-Year Follow-Up Study Comparing Event-Free Survival of SB3 Trastuzumab Biosimilar Candidate to Reference Trastuzumab by ADCC Activity
AR-HARVEST-HEALTH-&-RECR7.12.2018 20:02 | Pressemeddelelse
Harvest Health & Recreation, Inc. to hold Conference Call to Discuss Q3 2018 Results and Performance Outlook
DC-VELODYNE-LIDAR7.12.2018 15:03 | Pressemeddelelse
David Hall Wows Industry with New Technology Solution for Space Exploration
TN-FEDEX-CORP7.12.2018 15:02 | Pressemeddelelse
Raj Subramaniam Named as FedEx Express President and CEO
CQN-VÄRDE-PARTNERS7.12.2018 12:45 | Pressemeddelelse
CORRECTING and REPLACING The Dedica Anthology Completes Its Planned Refinancing
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum